Prokidney (PROK) Change in Interest Receivables (2023 - 2026)
Prokidney's (PROK) quarterly Change in Interest Receivables came in at -$95000.0 in Q1 2026, up 86.33% year-on-year from -$50984.6 in Q1 2025, and up 13.64% on a QoQ basis from -$110000.0 in Q4 2025.
Prokidney (PROK) Change in Interest Receivables (2023 - 2026) Analysis & Trends
Prokidney (PROK) has 4 years of Change in Interest Receivables data on file, last reported at -$95000.0 in Q1 2026.
- On a quarterly basis, Change in Interest Receivables rose 86.33% year-over-year to -$95000.0 in Q1 2026; TTM through Mar 2026 was -$720000.0, a 373.68% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 223.13% from the prior year.
- Change in Interest Receivables for Q1 2026 stood at -$95000.0, up from -$110000.0 in the prior quarter.
- Over the last five years, Change in Interest Receivables for PROK reached as high as $5.5 million in Q1 2023 and fell as low as -$7.4 million in Q3 2023.
- Historically, Change in Interest Receivables has averaged $79384.6 across 4 years, with a median of $23000.0 in 2025.
- On a YoY basis, Change in Interest Receivables climbed as much as 131.93% in 2024 and fell as far as 501.82% in 2024.
- Year by year, Change in Interest Receivables stood at $661000.0 in 2023, then tumbled by 501.82% to -$2.7 million in 2024, then soared by 95.86% to -$110000.0 in 2025, then grew by 13.64% to -$95000.0 in 2026.
- Per Business Quant data, the three most recent Change in Interest Receivables figures were -$95000.0 in Q1 2026, -$110000.0 in Q4 2025, and -$538000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | -95,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95,000.00 |
| Dec 31, 2025 | -110,000.00 |
| Sep 30, 2025 | -538,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | -695,000.00 |
| Dec 31, 2024 | -2.66 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | 844,000.00 |
| Mar 31, 2024 | 529,000.00 |
| Dec 31, 2023 | 661,000.00 |
| Sep 30, 2023 | -7.38 Mn |
| Jun 30, 2023 | 2.61 Mn |
| Mar 31, 2023 | 5.48 Mn |